Yong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yong Zhang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Zhengmei Lin
Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, Guangzhou, China
2 shared publications Zongshan Shen
Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China
2 shared publications- Chengbo Wang
Institute of Pediatric Medicine, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Henan China
1 shared publication - Chuanjiang Zhao
Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China
1 shared publication - Fan Chen
Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an, China
1 shared publication - Fei Xue
Institute of Material Physics & Chemistry, College of Science, Nanjing Forestry University, Nanjing 210037, P. R. China
1 shared publication
Latest Publications
- 17 November 2026
- Published by Wiley in Journal of Clinical Periodontology
Spatial Transcriptomic Analysis Suggests Inflammatory Heterogeneity and Stromal–Epithelial Transcriptional Differences in Peri‐Implantitis Tissues
Aim: To explore spatial inflammatory heterogeneity and associated stromal–epithelial transcriptional differences in peri‐implantitis tissues using high‐resolution spatial transcriptomics. Materials and Methods: This exploratory study applied Visium HD spatial transcriptomics to five peri‐implantitis lesions and four tooth‐associated healthy gingival reference tissues. Spatial barcodes were annotated by histology, marker expression and module scoring. BANKSY, GASTON, differential expression, Gene Ontology, public scRNA‐seq reanalysis, CellChat and multiplex immunofluorescence were used to assess inflammatory niches, stromal and epithelial gradients, epithelial gene sets and inferred signalling. Results: Peri‐implantitis lesions showed descriptively greater immune‐cell enrichment in an unmatched comparison with tooth‐associated gingival reference tissue. Fibroblasts in inflammation‐enriched niches differed from stromal‐region fibroblasts and COL11A1 ‐positive fibroblasts localised near immune‐rich areas. GASTON identified graded expression patterns along the epithelial–stromal interface and epithelial regions. An 11‐gene epithelial‐inflammation‐associated set showed region‐associated expression differences, with supportive expression trends in public epithelial scRNA‐seq data. CellChat suggested descriptively increased epithelial outgoing signalling involving WNT5A, MIF and ANXA1 . Conclusions: This study spatially describes host responses in peri‐implantitis, including regional inflammatory heterogeneity, fibroblast‐state variation and epithelial transcriptional differences. The epithelial‐inflammation‐associated gene set requires further validation. Interpretation should account for the small sample size, tooth‐associated gingival reference tissue, absence of microbiome profiling and barcode‐level Visium HD data.
- 17 November 2026
- Published by Wiley in Journal of Clinical Periodontology
Spatial Transcriptomic Analysis Suggests Inflammatory Heterogeneity and Stromal–Epithelial Transcriptional Differences in Peri‐Implantitis Tissues
Aim: To explore spatial inflammatory heterogeneity and associated stromal–epithelial transcriptional differences in peri‐implantitis tissues using high‐resolution spatial transcriptomics. Materials and Methods: This exploratory study applied Visium HD spatial transcriptomics to five peri‐implantitis lesions and four tooth‐associated healthy gingival reference tissues. Spatial barcodes were annotated by histology, marker expression and module scoring. BANKSY, GASTON, differential expression, Gene Ontology, public scRNA‐seq reanalysis, CellChat and multiplex immunofluorescence were used to assess inflammatory niches, stromal and epithelial gradients, epithelial gene sets and inferred signalling. Results: Peri‐implantitis lesions showed descriptively greater immune‐cell enrichment in an unmatched comparison with tooth‐associated gingival reference tissue. Fibroblasts in inflammation‐enriched niches differed from stromal‐region fibroblasts and COL11A1 ‐positive fibroblasts localised near immune‐rich areas. GASTON identified graded expression patterns along the epithelial–stromal interface and epithelial regions. An 11‐gene epithelial‐inflammation‐associated set showed region‐associated expression differences, with supportive expression trends in public epithelial scRNA‐seq data. CellChat suggested descriptively increased epithelial outgoing signalling involving WNT5A, MIF and ANXA1 . Conclusions: This study spatially describes host responses in peri‐implantitis, including regional inflammatory heterogeneity, fibroblast‐state variation and epithelial transcriptional differences. The epithelial‐inflammation‐associated gene set requires further validation. Interpretation should account for the small sample size, tooth‐associated gingival reference tissue, absence of microbiome profiling and barcode‐level Visium HD data.
- Open Access
- 28 April 2024
- Published by Elsevier in International Dental Journal
- Vol. 74 (4) , 823-835
Diabetic Macrophage Exosomal miR-381-3p Inhibits Epithelial Cell Autophagy Via NR5A2
- 28 April 2024
- Published by Elsevier in International Dental Journal
- Vol. 74 (4) , 823-835
Open AccessDiabetic Macrophage Exosomal miR-381-3p Inhibits Epithelial Cell Autophagy Via NR5A2
- Open Access
- 10 October 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 998600
Periodontitis induced by Porphyromonas gingivalis drives impaired glucose metabolism in mice
Periodontitis has been demonstrated to be bidirectionally associated with diabetes and has been recognized as a complication of diabetes. As a periodontal pathogen, Porphyromonas gingivalis is a possible pathogen linking periodontal disease and systemic diseases. It has also been found to be involved in the occurrence and development of diabetes. In this study, 6-week-old male C57BL/6 mice were orally administered the P. gingivalis strain ATCC381 for 22 weeks. Histological analysis of the gingival tissue and quantified analysis of alveolar bone loss were performed to evaluate periodontal destruction. Body weight, fasting glucose, glucose tolerance test (GTT), and insulin tolerance test (ITT) were used to evaluate glucose metabolism disorder. We then analyzed the expression profiles of inflammatory cytokines and chemokines in gingival tissue, the liver, and adipose tissue, as well as in serum. The results showed that mice in the P. gingivalis-administered group developed apparent gingival inflammation and more alveolar bone loss compared to the control group. After 22 weeks of P. gingivalis infection, significant differences were observed at 30 and 60 min for the GTT and at 15 min for the ITT. P. gingivalis-administered mice showed an increase in the mRNA expression levels of the pro-inflammatory cytokines (TNF-α, IL-6, IL-17, and IL-23) and chemokines (CCL2, CCL8, and CXCL10) in the gingiva and serum. The expression levels of the glucose metabolism-related genes were also changed in the liver and adipose tissue. Our results indicate that oral administration of P. gingivalis can induce changes in the inflammatory cytokines and chemokines in the gingiva and blood, can lead to alveolar bone loss and to inflammatory changes in the liver and adipose tissues, and can promote glucose metabolism disorder in mice.
- 10 October 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 998600
Open AccessPeriodontitis induced by Porphyromonas gingivalis drives impaired glucose metabolism in mice
Periodontitis has been demonstrated to be bidirectionally associated with diabetes and has been recognized as a complication of diabetes. As a periodontal pathogen, Porphyromonas gingivalis is a possible pathogen linking periodontal disease and systemic diseases. It has also been found to be involved in the occurrence and development of diabetes. In this study, 6-week-old male C57BL/6 mice were orally administered the P. gingivalis strain ATCC381 for 22 weeks. Histological analysis of the gingival tissue and quantified analysis of alveolar bone loss were performed to evaluate periodontal destruction. Body weight, fasting glucose, glucose tolerance test (GTT), and insulin tolerance test (ITT) were used to evaluate glucose metabolism disorder. We then analyzed the expression profiles of inflammatory cytokines and chemokines in gingival tissue, the liver, and adipose tissue, as well as in serum. The results showed that mice in the P. gingivalis-administered group developed apparent gingival inflammation and more alveolar bone loss compared to the control group. After 22 weeks of P. gingivalis infection, significant differences were observed at 30 and 60 min for the GTT and at 15 min for the ITT. P. gingivalis-administered mice showed an increase in the mRNA expression levels of the pro-inflammatory cytokines (TNF-α, IL-6, IL-17, and IL-23) and chemokines (CCL2, CCL8, and CXCL10) in the gingiva and serum. The expression levels of the glucose metabolism-related genes were also changed in the liver and adipose tissue. Our results indicate that oral administration of P. gingivalis can induce changes in the inflammatory cytokines and chemokines in the gingiva and blood, can lead to alveolar bone loss and to inflammatory changes in the liver and adipose tissues, and can promote glucose metabolism disorder in mice.
- Top Cited PapersOpen Access
- 1 December 2020
- Published by KEAI Publishing in Bioactive Materials
- Vol. 5 (4) , 1113-1126
Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism
Periodontitis is caused by host immune-inflammatory response to bacterial insult. A high proportion of pro-inflammatory macrophages to anti-inflammatory macrophages leads to the pathogenesis of periodontitis. As stem cell-derived exosomes can modulate macrophage phenotype, dental pulp stem cell-derived exosomes (DPSC-Exo) can effectively treat periodontitis. In this study, we demonstrated that DPSC-Exo-incorporated chitosan hydrogel (DPSC-Exo/CS) can accelerate the healing of alveolar bone and the periodontal epithelium in mice with periodontitis. Gene Ontology (GO) term enrichment analysis showed that treatment with DPSC-Exo/CS ameliorated periodontal lesion by suppressing periodontal inflammation and modulating the immune response. Specifically, DPSC-Exo/CS facilitated macrophages to convert from a pro-inflammatory phenotype to an anti-inflammatory phenotype in the periodontium of mice with periodontitis, the mechanism of which could be associated with miR-1246 in DPSC-Exo. These results not only shed light on the therapeutic mechanism of DPSC-Exo/CS but also provide the basis for developing an effective therapeutic approach for periodontitis.
- 1 December 2020
- Published by KEAI Publishing in Bioactive Materials
- Vol. 5 (4) , 1113-1126
Top Cited PapersOpen AccessChitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism
Periodontitis is caused by host immune-inflammatory response to bacterial insult. A high proportion of pro-inflammatory macrophages to anti-inflammatory macrophages leads to the pathogenesis of periodontitis. As stem cell-derived exosomes can modulate macrophage phenotype, dental pulp stem cell-derived exosomes (DPSC-Exo) can effectively treat periodontitis. In this study, we demonstrated that DPSC-Exo-incorporated chitosan hydrogel (DPSC-Exo/CS) can accelerate the healing of alveolar bone and the periodontal epithelium in mice with periodontitis. Gene Ontology (GO) term enrichment analysis showed that treatment with DPSC-Exo/CS ameliorated periodontal lesion by suppressing periodontal inflammation and modulating the immune response. Specifically, DPSC-Exo/CS facilitated macrophages to convert from a pro-inflammatory phenotype to an anti-inflammatory phenotype in the periodontium of mice with periodontitis, the mechanism of which could be associated with miR-1246 in DPSC-Exo. These results not only shed light on the therapeutic mechanism of DPSC-Exo/CS but also provide the basis for developing an effective therapeutic approach for periodontitis.
- Open Access
- 30 June 2019
- Published by Wiley in HemaSphere
- Vol. 3 (S1) , 27-28
PF150 ADAM28 OVEREXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA PROMOTE ITS INVASION IN CENTRAL NEURAL SYSTEM VIA CROSS TALKING WITH CXCR4 PATHWAY
Background: ADAM28 has been shown to relate with tumor proliferation, metastasis and prognosis. Our previous work showed that overexpression of ADAM28 in bone marrow of acute lymphoblastic leukemia (ALL) patients is related with poor prognosis. Central neural system (CNS) involvement is still a challenge in treatment of ALL and the mechanism is unknown. Our study revealed that the overexpression of ADAM28 might be one of the indicator and key mechanism in the occurrence of CNS leukemia.Aims: To explore the effect and mechanism of ADAM28 expression in ALL blast cell on its CNS metastasis.Methods: Bone marrow samples were collected from 50 ALL patients and 10 healthy donors. The expression of ADAM28 in BM were detected through flow cytometry. The tumor xenograft mouse model was established via the femoral vein injection of primary ALL cells or Nalm‐6 cell line after a sublethally irradiation and intraperitoneal injection with CD122 in male 8‐week‐old NOD/SCID mice. CNS symptoms such as seizures and paraplegia were observed after the injection of ALL cells. The mice were sacrificed on days 1, 3, 5, and 7 after injection respectively, and the brain, liver, spleen, kidney and BM were collected, samples were then embedded in paraffin. Sections were mounted on slides, deparaffinized and stained with hematoxylin and eosin (HE) or anti‐CD45 antibody. Knock‐down and overexpression of ADAM28 in primary ALL cells and cell line were achieved by transfection of ADAM28‐shRNA or ADAM28 plasmid. Ly294002 as ADAM28 inhibitor and CXCR4 Inhibitory antibody were added in the in vitro culture of primary ALL cells and cell lines. Transwell chambers were used to verify the migration and invasion ability of ALL cells. Western blot (WB) and RT‐PCR was performed to verify the expression level of ADAM28, CXCR4, IGFBP3 in order to analysis the cross talk between the two pathways.Results: The expression of ADAM28 in BM of ALL patients with CNSL were significantly higher than that in ALL patients without CNSL. In the xenograft mouse model, mice injected with ALL cells in which ADAM28 was overexpressed showed a significant higher incidence rate of seizures or paraplegia. The HE stain results showed that the involvement of brain and meninges in ADAM28 overexpress group was significantly higher than control, while there was no difference in liver, spleen and kidney invasion in the two groups. Clonal tracking experiments results that most of the ALL cells observed in brain and meninges of mice injected the mixture of ADAM28‐overexpression‐GFP ALL cells and empty plasmid ALL cells were GFP positive, which demonstrated that the invasion of ALL cells was increased when ADAM28 overexpressing. In vitro, transwell chamber results showed that the migration ability of ALL cells with high ADAM28 level was significantly higher than that of controls, and the migration ability was decreased when ADAM28 was knocked down or treated with ADAM28 inhibitor. Additional, when ADAM28 was knocked down, the expression of CXCR4 in mRNA level and protein level were decreased, and the ADAM28 expression level was decreased when decreased when treated with CXCR4 inhibitory antibodies, which suggested that there might be a cross talk between ADAM28 and CXCR4 signaling pathway.Summary/Conclusion: The incidence of CNSL in ADAM28 overexpressing ALL patients was increased. The invasion into CNS of ALL cells was increased when ADAM28 was overexpressed in xenograft mouse model. ADAM28 might promote the migration and invasion ability via cross talking with CXCR4 pathway.
- 30 June 2019
- Published by Wiley in HemaSphere
- Vol. 3 (S1) , 27-28
Open AccessPF150 ADAM28 OVEREXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA PROMOTE ITS INVASION IN CENTRAL NEURAL SYSTEM VIA CROSS TALKING WITH CXCR4 PATHWAY
Background: ADAM28 has been shown to relate with tumor proliferation, metastasis and prognosis. Our previous work showed that overexpression of ADAM28 in bone marrow of acute lymphoblastic leukemia (ALL) patients is related with poor prognosis. Central neural system (CNS) involvement is still a challenge in treatment of ALL and the mechanism is unknown. Our study revealed that the overexpression of ADAM28 might be one of the indicator and key mechanism in the occurrence of CNS leukemia.Aims: To explore the effect and mechanism of ADAM28 expression in ALL blast cell on its CNS metastasis.Methods: Bone marrow samples were collected from 50 ALL patients and 10 healthy donors. The expression of ADAM28 in BM were detected through flow cytometry. The tumor xenograft mouse model was established via the femoral vein injection of primary ALL cells or Nalm‐6 cell line after a sublethally irradiation and intraperitoneal injection with CD122 in male 8‐week‐old NOD/SCID mice. CNS symptoms such as seizures and paraplegia were observed after the injection of ALL cells. The mice were sacrificed on days 1, 3, 5, and 7 after injection respectively, and the brain, liver, spleen, kidney and BM were collected, samples were then embedded in paraffin. Sections were mounted on slides, deparaffinized and stained with hematoxylin and eosin (HE) or anti‐CD45 antibody. Knock‐down and overexpression of ADAM28 in primary ALL cells and cell line were achieved by transfection of ADAM28‐shRNA or ADAM28 plasmid. Ly294002 as ADAM28 inhibitor and CXCR4 Inhibitory antibody were added in the in vitro culture of primary ALL cells and cell lines. Transwell chambers were used to verify the migration and invasion ability of ALL cells. Western blot (WB) and RT‐PCR was performed to verify the expression level of ADAM28, CXCR4, IGFBP3 in order to analysis the cross talk between the two pathways.Results: The expression of ADAM28 in BM of ALL patients with CNSL were significantly higher than that in ALL patients without CNSL. In the xenograft mouse model, mice injected with ALL cells in which ADAM28 was overexpressed showed a significant higher incidence rate of seizures or paraplegia. The HE stain results showed that the involvement of brain and meninges in ADAM28 overexpress group was significantly higher than control, while there was no difference in liver, spleen and kidney invasion in the two groups. Clonal tracking experiments results that most of the ALL cells observed in brain and meninges of mice injected the mixture of ADAM28‐overexpression‐GFP ALL cells and empty plasmid ALL cells were GFP positive, which demonstrated that the invasion of ALL cells was increased when ADAM28 overexpressing. In vitro, transwell chamber results showed that the migration ability of ALL cells with high ADAM28 level was significantly higher than that of controls, and the migration ability was decreased when ADAM28 was knocked down or treated with ADAM28 inhibitor. Additional, when ADAM28 was knocked down, the expression of CXCR4 in mRNA level and protein level were decreased, and the ADAM28 expression level was decreased when decreased when treated with CXCR4 inhibitory antibodies, which suggested that there might be a cross talk between ADAM28 and CXCR4 signaling pathway.Summary/Conclusion: The incidence of CNSL in ADAM28 overexpressing ALL patients was increased. The invasion into CNS of ALL cells was increased when ADAM28 was overexpressed in xenograft mouse model. ADAM28 might promote the migration and invasion ability via cross talking with CXCR4 pathway.